Asset
Sufentanil
Revenue
No revenue reported in loaded filings.
Clinical trials (3)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02662556 | phase3 | completed | 2016-03-01 | 2016-06-01 | Talphera, Inc | A Multicenter, Open-Label Trial to Evaluate the Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg in Patients With Post-Operative Pain |
| NCT02356588 | phase3 | completed | 2015-02-01 | 2015-06-01 | Talphera, Inc | A Trial Evaluating the Efficacy and Safety of the Sublingual Sufentanil Tablet 30 mcg for Post-Operative Pain After Abdominal Surgery |
| NCT02447848 | phase3 | completed | 2015-10-01 | 2016-06-01 | Talphera, Inc | Open-Label Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg for Acute Pain |
FDA applications (0)
This company has no applications containing this asset.